Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers
FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
SVB Leerink Maintains Outperform on Vincerx Pharma, Lowers Price Target to $5
SVB Leerink analyst Jonathan Chang maintains Vincerx Pharma (NASDAQ:VINC) with a Outperform and lowers the price target from $6 to $5.
Cantor Fitzgerald Maintains Overweight on Vincerx Pharma, Lowers Price Target to $8
Cantor Fitzgerald analyst Li Watsek maintains Vincerx Pharma (NASDAQ:VINC) with a Overweight and lowers the price target from $22 to $8.
Analysts Cuts Price Target On This Small Cap But Remain Bullish
Chardan analyst Matthew Barcus lowered the price target on Vincerx Pharma Inc (NASDAQ:VINC) to $4 from $11 and kept a Buy rating…
7 Analysts Have This to Say About Vincerx Pharma
Within the last quarter, Vincerx Pharma (NASDAQ:VINC) has observed the following analyst ratings:
Small Cap Biotech Vincerx Cuts Third Of Staff
Cancer-focused biotech Vincerx Pharma Inc (NASDAQ: VINC) would lay off 33% of its staff to get its lead program through two Phase I studies.
B. Riley Securities Maintains Buy on Vincerx Pharma, Lowers Price Target to $6
B. Riley Securities analyst Kalpit Patel maintains Vincerx Pharma (NASDAQ:VINC) with a Buy and lowers the price target from $12 to $6.